RehabilitationNEUROSTABNCT07029620
Peripheral Neuropathy Rehabilitation With Stabilometric Platforms (NEUROSTAB)
A study testing Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditions, Conventional balance and gait rehabilitation program and Stabilometric assessment in healthy volunteers in people with Rehabilitation and Balance, run by Ospedale Policlinico San Martino.
Trial summary
The goal of this clinical trial is to learn if the GeaMaster stabilometric platform can support rehabilitation and improve balance and walking ability in adults diagnosed with peripheral neuropathy. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Rehabilitation, Balance
- What is being tested?
- Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditions, Conventional balance and gait rehabilitation program and Stabilometric assessment in healthy volunteers
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 25 Jun 2025to 20 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy subjects aged between 18 and 80 years
- Patients aged between 18 and 80 years with a diagnosis of peripheral neuropathy, according to international criteria
- Patients must be at an equivalent stage of disease
- Patients must be undergoing comparable and analogous treatments
- Pharmacological treatment stability during the last 6 months
Who cannot join
- Severe comorbidity
- Presence of other neurological disorders or balance alterations due to other diseases (e.g., vestibular or cerebellar conditions)
- Pain with VAS >3 in any body region
- Orthopedic surgery within the past 6 months
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Evaluation and Rehabilitation of Patients With Peripheral Neuropathy Using Static and Dynamic Stabilometric Platforms: NEUROSTAB
The goal of this clinical trial is to learn if the GeaMaster stabilometric platform can support rehabilitation and improve balance and walking ability in adults diagnosed with peripheral neuropathy. It will also evaluate whether the platform can provide objective and reliable data that match the results of standard clinical tests. The study will explore if brain and muscle activity, recorded during movement, can indicate how much motor learning and recovery has occurred.
Peripheral neuropathies are disorders of the peripheral nerves and can have many causes, including diabetes, autoimmune diseases, toxins, or inherited conditions such as Charcot-Marie-Tooth disease. Symptoms may include reduced sensation, muscle weakness, poor reflexes, balance problems, and frequent falls. Since there are no approved drugs for many of these conditions, physical therapy is the main treatment option.
Read more
The main questions this study aims to answer are:
- Does using GeaMaster improve balance and walking better than traditional rehabilitation alone?
- Are GeaMaster's stabilometric data consistent with standard balance and gait test scores?
- Can movement-related evoked potentials be used as biomarkers to track and predict motor recovery? To answer these questions, researchers will compare two groups of patients. One group will receive traditional physiotherapy. The other group will receive the same therapy with the support of the GeaMaster platform. Both groups will follow the treatment for 4 weeks. A group of healthy volunteers will also be included for comparison.
Participants will:
- Be adults aged 18 to 80. Patients must have a diagnosis of peripheral neuropathy and a stable condition.
- Be randomly assigned to a control group (traditional rehab) or experimental group (rehab with GeaMaster).
- Visit the clinic for balance and walking tests at three time points: before treatment (T0), after 4 weeks of treatment (T1), and 1 month later (T2).
- Complete clinical tests such as the Berg Balance Scale, 6-Minute Walk Test, 10-Meter Walk Test, Tinetti Scale, and Modified Barthel Index.
- Be assessed using the GeaMaster platform for postural stability under both static and dynamic conditions.
- Undergo neurophysiological tests using EEG and EMG to record brain and muscle activity during tasks like walking, writing, or drawing.
Healthy volunteers will visit the clinic twice (5 days apart) to check how stable the GeaMaster measurements are over time.
GeaMaster is a robotic platform that uses compressed air to gently move the support surface and challenge a patient's balance. It offers different levels of difficulty and provides real-time visual feedback. Its design avoids mechanical inertia, making movements feel more natural and safe for patients of all ages.
The main outcome researchers will look for is a significant link between GeaMaster balance data and results of the Berg Balance Scale and the 10-Meter Walk Test. Other outcomes include performance on additional scales, the presence of balance improvements, risk of falling, and changes in movement-related brain signals.
- Conditions
- Rehabilitation, Balance
- Being tested
- Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditions, Conventional balance and gait rehabilitation program, Stabilometric assessment in healthy volunteers
- Keywords
- Peripheral Neuropathy, Postural Control, Stabilometric Platform, Dynamic Balance, Static Balance, Rehabilitation, Neurorehabilitation, Balance Training
- Medical subject headings
- Peripheral Nervous System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditionsDevice
This intervention consists of a structured postural rehabilitation program supported by the GEAMASTER stabilometric platform. The device provides real-time feedback on center-of-pressure shifts and enables both static and dynamic balance training through interactive visual tasks. Exercises include multi-directional weight shifting, stability control, and task-specific balance strategies. The platform integrates sensor-based tracking and allows fine-grained analysis of postural parameters, distinguishing it from conventional physiotherapy by its precision, adaptability, and real-time feedback mechanisms.
Conventional balance and gait rehabilitation programOther
This intervention consists of a standardized physiotherapy program aimed at improving postural control and gait in patients with peripheral neuropathy. The rehabilitation protocol includes stretching, weight-shifting exercises, balance training on foam or unstable surfaces, and obstacle navigation. Unlike the experimental intervention, this program does not use any technological or sensor-based feedback systems. The content, frequency, and duration of the sessions are matched to those of the experimental arm to allow for comparative analysis of clinical outcomes.
Stabilometric assessment in healthy volunteersOther
This intervention involves a non-interventional assessment of healthy adult volunteers using the GEAMASTER stabilometric platform. The objective is to generate normative data for stabilometric parameters and to assess test-retest reliability of the device under static and dynamic conditions. Participants do not undergo any rehabilitation program or therapeutic intervention. The data collected will serve as a reference for interpreting pathological findings in patients with peripheral neuropathy.
| Study group | Role | What they receive |
|---|---|---|
| Instrumented Balance (GeaMaster) Training Group | Experimental | Participants in this arm are patients diagnosed with peripheral neuropathy who will undergo a structured rehabilitation program supported by the GEAMASTER stabilometric platform. The intervention involves balance training sessions during which the GEAMASTER device provides real-time postural feedback by measuring center-of-pressure shifts under both static and dynamic conditions. Receives: Device: Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditions |
| Active Comparator: Traditional Rehabilitation Training Group | Active comparator | Participants in this arm are patients diagnosed with peripheral neuropathy who will undergo a structured rehabilitation program using traditional physiotherapy methods. The intervention includes balance and gait training exercises without technological support, such as weight shifting, static and dynamic balance tasks, and obstacle navigation performed on conventional surfaces. Receives: Other: Conventional balance and gait rehabilitation program |
| Reference Arm: Healthy Subjects Group | Other | Participants in this arm are healthy individuals with no history of neurological or balance disorders who will undergo stabilometric assessments using the GEAMASTER platform. The purpose of this arm is to establish normative data and evaluate the test-retest reliability of the device under both static and dynamic conditions. Receives: Other: Stabilometric assessment in healthy volunteers |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation between sway area and sway path values and scores on the Berg Balance Scale
Measured: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Correlation between sway area and sway path values and performance on the 10-Meter Walk Test
Measured: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Secondary outcomes (3)
Correlation between additional stabilometric parameters (static balance, dynamic balance, fall risk, and mobility) and clinical outcomes
Measured: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Temporal and frequency domain analysis of movement-related cortical potentials in upper and lower limbs
Measured: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Comparison of movement-related cortical activity in upper versus lower limbs to evaluate motor learning effects
Measured: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jun 2025
- Study start25 Jun 2025 (estimated)
- Primary completion20 May 2026 (estimated)
- Study completion20 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Study type: interventional. Allocation: randomized Intervention model: parallel assignment (1:1) This study involves two treatment groups of patients with peripheral neuropathies and one additional non-treatment group of healthy subjects. The healthy control group is not part of the therapeutic comparison; rather, it is included exclusively for the purpose of evaluating the reproducibility of the stabilometric measurements recorded with the GEAMASTER platform. The main comparison of treatment efficacy is conducted only between the two patient groups.
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ospedale Policlinico San Martino
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07029620
- Sponsor's protocol ID
- NEUROSTAB - PNC0000007
- Other IDs
- #PNC0000007
- Acronym
- NEUROSTAB
- Status last verified
- Apr 2025
- First submitted
- 11 Jun 2025
- Last updated
- 19 Jun 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Baratto L, Morasso PG, Re C, Spada G. A new look at posturographic analysis in the clinical context: sway-density versus other parameterization techniques. Motor Control. 2002 Jul;6(3):246-70. doi: 10.1123/mcj.6.3.246.
PubMed 12122219Scoppa F, Capra R, Gallamini M, Shiffer R. Clinical stabilometry standardization: basic definitions--acquisition interval--sampling frequency. Gait Posture. 2013 Feb;37(2):290-2. doi: 10.1016/j.gaitpost.2012.07.009. Epub 2012 Aug 11.
PubMed 22889928Wright DJ, Holmes PS, Smith D. Using the movement-related cortical potential to study motor skill learning. J Mot Behav. 2011;43(3):193-201. doi: 10.1080/00222895.2011.557751.
PubMed 21462065Shibasaki H. Cortical activities associated with voluntary movements and involuntary movements. Clin Neurophysiol. 2012 Feb;123(2):229-43. doi: 10.1016/j.clinph.2011.07.042. Epub 2011 Sep 8.
PubMed 21906995Prada V, Mori L, Accogli S, Rivarola M, Schizzi S, Hamedani M, Schenone A. Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? J Peripher Nerv Syst. 2018 Jun;23(2):124-128. doi: 10.1111/jns.12270. Epub 2018 May 7.
PubMed 29693294Gess B, Baets J, De Jonghe P, Reilly MM, Pareyson D, Young P. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease. Cochrane Database Syst Rev. 2015 Dec 11;2015(12):CD011952. doi: 10.1002/14651858.CD011952.
PubMed 26662471Rose KJ, Hiller CE, Mandarakas M, Raymond J, Refshauge K, Burns J. Correlates of functional ankle instability in children and adolescents with Charcot-Marie-Tooth disease. J Foot Ankle Res. 2015 Nov 5;8:61. doi: 10.1186/s13047-015-0118-1. eCollection 2015.
PubMed 26543504Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006;8(1-2):3-22. doi: 10.1385/nmm:8:1-2:3.
PubMed 16775364Eggermann K, Gess B, Hausler M, Weis J, Hahn A, Kurth I. Hereditary Neuropathies. Dtsch Arztebl Int. 2018 Feb 9;115(6):91-97. doi: 10.3238/arztebl.2018.0091.
PubMed 29478438Mathis S, Magy L, Le Masson G, Richard L, Soulages A, Sole G, Duval F, Ghorab K, Vallat JM, Duchesne M. Value of nerve biopsy in the management of peripheral neuropathies. Expert Rev Neurother. 2018 Jul;18(7):589-602. doi: 10.1080/14737175.2018.1489240. Epub 2018 Jun 25.
PubMed 29923431
Study at a glance
From the registry record, last updated by the sponsor on 19 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation and Rehabilitation of Patients With Peripheral Neuropathy Using Static and Dynamic Stabilometric Platforms: NEUROSTAB
- ClinicalTrials.gov ID
- NCT07029620
- Acronym / sponsor ID
- NEUROSTAB / NEUROSTAB - PNC0000007
- Conditions
- Rehabilitation, Balance
- Keywords
- Peripheral Neuropathy, Postural Control, Stabilometric Platform, Dynamic Balance, Static Balance, Rehabilitation, Neurorehabilitation, Balance Training
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Ospedale Policlinico San MartinoUniversity, hospital or other
- Study start
- 25 Jun 2025 (estimated)
- Primary completion
- 20 May 2026 (estimated)
- Study completion
- 20 Jun 2026 (estimated)
- First posted
- 19 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if the GeaMaster stabilometric platform can support rehabilitation and improve balance and walking ability in adults diagnosed with peripheral neuropathy. It will also evaluate whether the platform can provide objective and reliable data that match the results of standard clinical tests. The study will explore if brain and muscle activity, recorded during movement, can indicate how much motor learning and recovery has occurred.
Peripheral neuropathies are disorders of the peripheral nerves and can have many causes, including diabetes, autoimmune diseases, toxins, or inherited conditions such as Charcot-Marie-Tooth disease. Symptoms may include reduced sensation, muscle weakness, poor reflexes, balance problems, and frequent falls. Since there are no approved drugs for many of these conditions, physical therapy is the main treatment option.
The main questions this study aims to answer are:
- Does using GeaMaster improve balance and walking better than traditional rehabilitation alone?
- Are GeaMaster's stabilometric data consistent with standard balance and gait test scores?
- Can movement-related evoked potentials be used as biomarkers to track and predict motor recovery? To answer these questions, researchers will compare two groups of patients. One group will receive traditional physiotherapy. The other group will receive the same therapy with the support of the GeaMaster platform. Both groups will follow the treatment for 4 weeks. A group of healthy volunteers will also be included for comparison.
Participants will:
- Be adults aged 18 to 80. Patients must have a diagnosis of peripheral neuropathy and a stable condition.
- Be randomly assigned to a control group (traditional rehab) or experimental group (rehab with GeaMaster).
- Visit the clinic for balance and walking tests at three time points: before treatment (T0), after 4 weeks of treatment (T1), and 1 month later (T2).
- Complete clinical tests such as the Berg Balance Scale, 6-Minute Walk Test, 10-Meter Walk Test, Tinetti Scale, and Modified Barthel Index.
- Be assessed using the GeaMaster platform for postural stability under both static and dynamic conditions.
- Undergo neurophysiological tests using EEG and EMG to record brain and muscle activity during tasks like walking, writing, or drawing.
Healthy volunteers will visit the clinic twice (5 days apart) to check how stable the GeaMaster measurements are over time.
GeaMaster is a robotic platform that uses compressed air to gently move the support surface and challenge a patient's balance. It offers different levels of difficulty and provides real-time visual feedback. Its design avoids mechanical inertia, making movements feel more natural and safe for patients of all ages.
The main outcome researchers will look for is a significant link between GeaMaster balance data and results of the Berg Balance Scale and the 10-Meter Walk Test. Other outcomes include performance on additional scales, the presence of balance improvements, risk of falling, and changes in movement-related brain signals.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 3
- Model description
- Study type: interventional. Allocation: randomized Intervention model: parallel assignment (1:1) This study involves two treatment groups of patients with peripheral neuropathies and one additional non-treatment group of healthy subjects. The healthy control group is not part of the therapeutic comparison; rather, it is included exclusively for the purpose of evaluating the reproducibility of the stabilometric measurements recorded with the GEAMASTER platform. The main comparison of treatment efficacy is conducted only between the two patient groups.
| Arm | Type | Receives |
|---|---|---|
| Instrumented Balance (GeaMaster) Training Group | Experimental | Device: Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditionsParticipants in this arm are patients diagnosed with peripheral neuropathy who will undergo a structured rehabilitation program supported by the GEAMASTER stabilometric platform. The intervention involves balance training sessions during which the GEAMASTER device provides real-time postural feedback by measuring center-of-pressure shifts under both static and dynamic conditions. |
| Active Comparator: Traditional Rehabilitation Training Group | Active comparator | Other: Conventional balance and gait rehabilitation programParticipants in this arm are patients diagnosed with peripheral neuropathy who will undergo a structured rehabilitation program using traditional physiotherapy methods. The intervention includes balance and gait training exercises without technological support, such as weight shifting, static and dynamic balance tasks, and obstacle navigation performed on conventional surfaces. |
| Reference Arm: Healthy Subjects Group | Other | Other: Stabilometric assessment in healthy volunteersParticipants in this arm are healthy individuals with no history of neurological or balance disorders who will undergo stabilometric assessments using the GEAMASTER platform. The purpose of this arm is to establish normative data and evaluate the test-retest reliability of the device under both static and dynamic conditions. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Healthy subjects aged between 18 and 80 years
- Patients aged between 18 and 80 years with a diagnosis of peripheral neuropathy, according to international criteria
- Patients must be at an equivalent stage of disease
- Patients must be undergoing comparable and analogous treatments
- Pharmacological treatment stability during the last 6 months
Key exclusion criteria (4 listed)
- Severe comorbidity
- Presence of other neurological disorders or balance alterations due to other diseases (e.g., vestibular or cerebellar conditions)
- Pain with VAS >3 in any body region
- Orthopedic surgery within the past 6 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditionsThis intervention consists of a structured postural rehabilitation program supported by the GEAMASTER stabilometric platform. The device provides real-time feedback on center-of-pressure shifts and enables both static and dynamic balance training through interactive visual tasks. Exercises include multi-directional weight shifting, stability control, and task-specific balance strategies. The platform integrates sensor-based tracking and allows fine-grained analysis of postural parameters, distinguishing it from conventional physiotherapy by its precision, adaptability, and real-time feedback mechanisms. | Device | Instrumented Balance (GeaMaster) Training Group |
| Conventional balance and gait rehabilitation programThis intervention consists of a standardized physiotherapy program aimed at improving postural control and gait in patients with peripheral neuropathy. The rehabilitation protocol includes stretching, weight-shifting exercises, balance training on foam or unstable surfaces, and obstacle navigation. Unlike the experimental intervention, this program does not use any technological or sensor-based feedback systems. The content, frequency, and duration of the sessions are matched to those of the experimental arm to allow for comparative analysis of clinical outcomes. | Other | Active Comparator: Traditional Rehabilitation Training Group |
| Stabilometric assessment in healthy volunteersThis intervention involves a non-interventional assessment of healthy adult volunteers using the GEAMASTER stabilometric platform. The objective is to generate normative data for stabilometric parameters and to assess test-retest reliability of the device under static and dynamic conditions. Participants do not undergo any rehabilitation program or therapeutic intervention. The data collected will serve as a reference for interpreting pathological findings in patients with peripheral neuropathy. | Other | Reference Arm: Healthy Subjects Group |
Primary outcome
Correlation between sway area and sway path values and scores on the Berg Balance Scale
Time frame: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Correlation between sway area and sway path values and performance on the 10-Meter Walk Test
Time frame: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
3 secondary outcomes
Correlation between additional stabilometric parameters (static balance, dynamic balance, fall risk, and mobility) and clinical outcomes
Time frame: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Temporal and frequency domain analysis of movement-related cortical potentials in upper and lower limbs
Time frame: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Comparison of movement-related cortical activity in upper versus lower limbs to evaluate motor learning effects
Time frame: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jun 2025.
- Results publication: PubMed 12122219Baratto L, Morasso PG, Re C, Spada G. A new look at posturographic analysis in the clinical context: sway-density versus other parameterization techniques. Motor Control. 2002 Jul;6(3):246-70. doi: 10.1123/mcj.6.3.246.
- Results publication: PubMed 22889928Scoppa F, Capra R, Gallamini M, Shiffer R. Clinical stabilometry standardization: basic definitions--acquisition interval--sampling frequency. Gait Posture. 2013 Feb;37(2):290-2. doi: 10.1016/j.gaitpost.2012.07.009. Epub 2012 Aug 11.
- Results publication: PubMed 21462065Wright DJ, Holmes PS, Smith D. Using the movement-related cortical potential to study motor skill learning. J Mot Behav. 2011;43(3):193-201. doi: 10.1080/00222895.2011.557751.
- Results publication: PubMed 21906995Shibasaki H. Cortical activities associated with voluntary movements and involuntary movements. Clin Neurophysiol. 2012 Feb;123(2):229-43. doi: 10.1016/j.clinph.2011.07.042. Epub 2011 Sep 8.
- Results publication: PubMed 29693294Prada V, Mori L, Accogli S, Rivarola M, Schizzi S, Hamedani M, Schenone A. Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? J Peripher Nerv Syst. 2018 Jun;23(2):124-128. doi: 10.1111/jns.12270. Epub 2018 May 7.
- Results publication: PubMed 26662471Gess B, Baets J, De Jonghe P, Reilly MM, Pareyson D, Young P. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease. Cochrane Database Syst Rev. 2015 Dec 11;2015(12):CD011952. doi: 10.1002/14651858.CD011952.
- Results publication: PubMed 26543504Rose KJ, Hiller CE, Mandarakas M, Raymond J, Refshauge K, Burns J. Correlates of functional ankle instability in children and adolescents with Charcot-Marie-Tooth disease. J Foot Ankle Res. 2015 Nov 5;8:61. doi: 10.1186/s13047-015-0118-1. eCollection 2015.
- Results publication: PubMed 16775364Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006;8(1-2):3-22. doi: 10.1385/nmm:8:1-2:3.
- Results publication: PubMed 29478438Eggermann K, Gess B, Hausler M, Weis J, Hahn A, Kurth I. Hereditary Neuropathies. Dtsch Arztebl Int. 2018 Feb 9;115(6):91-97. doi: 10.3238/arztebl.2018.0091.
- Results publication: PubMed 29923431Mathis S, Magy L, Le Masson G, Richard L, Soulages A, Sole G, Duval F, Ghorab K, Vallat JM, Duchesne M. Value of nerve biopsy in the management of peripheral neuropathies. Expert Rev Neurother. 2018 Jul;18(7):589-602. doi: 10.1080/14737175.2018.1489240. Epub 2018 Jun 25.
- Individual participant dataSharing planned: No
Related trials for Rehabilitation
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Sensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy
Cerebral Palsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditions, Conventional balance and gait rehabilitation program and Stabilometric assessment in healthy volunteers in people with Rehabilitation and Balance, run by Ospedale Policlinico San Martino.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Angelo Schenone, MD (0039-3537040, angelo.schenone@unige.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation between sway area and sway path values and scores on the Berg Balance Scale (time frame: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07029620, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2025.